Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FVKKL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injectors. This firm fixed price contract, awarded on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The pharmaceutical product being supplied is a specialized biologic medication used in dermatological treatment, reflecting the company's role as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The firm's federal contracting history demonstrates extensive experience fulfilling varied pharmaceutical delivery orders through competitive procurement processes, positioning it as a key supplier within DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FVKKL?
SPE2DB25FVKKL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FVKKL worth?
The government has obligated $11,830 on SPE2DB25FVKKL.
Is contract SPE2DB25FVKKL an order under another contract?
Yes. SPE2DB25FVKKL is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKKL competed?
The extent of competition for SPE2DB25FVKKL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award